What antibiotic should be used for stasis mastitis in a breastfeeding mother?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Antibiotic Choice for Stasis Mastitis in Breastfeeding

For lactational mastitis in breastfeeding mothers, prescribe dicloxacillin 500 mg four times daily or cephalexin 500 mg four times daily for 10-14 days, and strongly encourage continued breastfeeding throughout treatment. 1

First-Line Antibiotic Selection

The primary antibiotics for mastitis target Staphylococcus aureus, the predominant pathogen:

  • Dicloxacillin: 500 mg orally four times daily 1
  • Cephalexin: 500 mg orally four times daily 1

These anti-staphylococcal penicillins and first-generation cephalosporins are considered safe during breastfeeding and are secreted minimally into breast milk 2. Australian data confirms these remain the most commonly prescribed agents (dicloxacillin/flucloxacillin 59.4%, cephalexin 27.5%) 3.

Treatment Duration and Approach

Treat for 10-14 days 4, 5. The most recent 2025 guidelines from the American Society of Breast Surgeons specify at least 10 days when a phlegmon is present 5.

Critical Management Principles:

  1. Continue breastfeeding - This is essential and does not pose risk to the infant 6, 4. Regular feeding or milk expression is actually therapeutic 6

  2. Effective milk removal first - Before antibiotics, ensure proper breast emptying through frequent nursing or expression 7, 4

  3. Distinguish infectious from non-infectious mastitis - Only infectious mastitis requires antibiotics; non-infectious cases need supportive care only 5

Alternative Regimens

For Penicillin Allergy:

  • Clindamycin: 300-450 mg orally three times daily 1
  • Note: Erythromycin resistance is increasingly common, limiting its utility 1

For MRSA Concerns:

If methicillin-resistant S. aureus is suspected (increasingly common, with >90% of mastitis isolates being MRSA in recent studies 8):

  • TMP-SMZ: 1-2 double-strength tablets twice daily 1
  • Doxycycline: 100 mg twice daily 1
  • Recent 2025 data shows vancomycin combinations may be needed for severe MDR-MRSA cases, but this requires IV administration 8

Common Pitfalls to Avoid

Do NOT stop breastfeeding - Approximately 10% of mastitis cases progress to abscess 6, often because of inadequate milk removal. Continued nursing prevents this complication.

Do NOT use antibiotics alone - Milk stasis is the underlying problem. Antibiotics without addressing milk removal will fail 7, 4.

Do NOT prescribe short courses - Courses shorter than 10 days lead to recurrence 4, 5.

Do NOT routinely order cultures - Only ~1% of encounters include breast milk cultures 3. Reserve cultures for treatment failures or suspected abscess.

When to Escalate Care

Refer for surgical evaluation if:

  • Fluctuance develops (suggests abscess requiring drainage) 6, 5
  • No improvement after 48-72 hours of appropriate antibiotics 4
  • Thick fluid collections form (may need stab incision with drain placement, not packing) 5

The 2025 guidelines emphasize that operative drainage is only needed if office procedures cannot be tolerated 5.

Safety in Breastfeeding

Penicillins, cephalosporins, and erythromycin are all considered safe during lactation 2. The infant can continue nursing even from the affected breast as long as their mouth does not contact purulent drainage 6.

References

Research

Management of mastitis in breastfeeding women.

American family physician, 2008

Research

Management of mastitis and breast engorgement in breastfeeding women.

The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 2016

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.